Continual lymphocytic leukemia (CLL) is often a lymphoid malignancy characterised via the proliferation and accumulation of mature CD5+ B cells inside the blood, bone marrow and lymphoid tissues. The prognosis of CLL necessitates the existence of ≥five x109/L mono - clonal B cells of typical phen